Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development

Quantitative and systems pharmacology (QSP) is an emerging modelling technique that combines the flexibility of systems biology and tractability of compartmental pharmacokinetic–pharmacodynamic modelling techniques. Historically, there has been extensive use of QSP within the field of pharmacokineti...

Full description

Saved in:
Bibliographic Details
Published in:Drug discovery today 2011-12, Vol.16 (23), p.1031-1036
Main Authors: Agoram, Balaji M., Demin, Oleg
Format: Article
Language:English
Subjects:
Animals
Drug Design
Drug Discovery - methods
Humans
Models, Biological
Pharmacology - methods
Systems Biology - methods
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c361t-69303f38066238bce2a57d5bc92940ce17ade935f8f81f7fcb36deb831b28a753
cites cdi_FETCH-LOGICAL-c361t-69303f38066238bce2a57d5bc92940ce17ade935f8f81f7fcb36deb831b28a753
container_end_page 1036
container_issue 23
container_start_page 1031
container_title Drug discovery today
container_volume 16
creator Agoram, Balaji M.
Demin, Oleg
description Quantitative and systems pharmacology (QSP) is an emerging modelling technique that combines the flexibility of systems biology and tractability of compartmental pharmacokinetic–pharmacodynamic modelling techniques. Historically, there has been extensive use of QSP within the field of pharmacokinetics to optimise drug biopharmaceutical properties. However, application to target and biomarker selection, and design of preclinical and clinical studies is limited, but growing rapidly. In this article we highlight the impact of QSP within drug discovery and development by citing examples from within the field of pharmacology and we argue for a more systematic integration of QSP within the drug discovery and development paradigm.
doi_str_mv 10.1016/j.drudis.2011.10.001
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_907036542</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1359644611003400</els_id><sourcerecordid>907036542</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-69303f38066238bce2a57d5bc92940ce17ade935f8f81f7fcb36deb831b28a753</originalsourceid><addsrcrecordid>eNp9kEtv3CAUhVGUqnm0_yCq2GXlCQ8b4y4qVVFeUqRs2jXCcO0wsmECeKL592EyaZdZcbn6zr3nHoQuKFlRQsXVemXjYl1aMUJpaa0IoUfolMpWVo3k7LjUvOkqUdfiBJ2ltC4A6xrxFZ0wRopK0lP0-uAzjFFnFzz2IWOXwvT--4l1HBfnR5yfARudAA8h4pdF--xyQbaAtbc47VKGOeHNs46zNmEK4w47j4u7ERd_Jmwh7t5RC1uYwmYGn7-hL4OeEnz_eM_R39ubP9f31ePT3cP178fKcEFzJTpO-MAlEYJx2Rtgumlt05uOdTUxQFttoePNIAdJh3YwPRcWeslpz6RuG36OLg9zNzG8LJCymoslmCbtISxJdaQlXDQ1K2R9IE0MKUUY1Ca6WcedokTtE1drdUhc7RPfd0ugRfbjY8HSz2D_i_5FXIBfBwDKmVsHUSXjwBuwLoLJygb3-YY3VaCWng</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>907036542</pqid></control><display><type>article</type><title>Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development</title><source>Elsevier</source><creator>Agoram, Balaji M. ; Demin, Oleg</creator><creatorcontrib>Agoram, Balaji M. ; Demin, Oleg</creatorcontrib><description>Quantitative and systems pharmacology (QSP) is an emerging modelling technique that combines the flexibility of systems biology and tractability of compartmental pharmacokinetic–pharmacodynamic modelling techniques. Historically, there has been extensive use of QSP within the field of pharmacokinetics to optimise drug biopharmaceutical properties. However, application to target and biomarker selection, and design of preclinical and clinical studies is limited, but growing rapidly. In this article we highlight the impact of QSP within drug discovery and development by citing examples from within the field of pharmacology and we argue for a more systematic integration of QSP within the drug discovery and development paradigm.</description><identifier>ISSN: 1359-6446</identifier><identifier>EISSN: 1878-5832</identifier><identifier>DOI: 10.1016/j.drudis.2011.10.001</identifier><identifier>PMID: 22020181</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Drug Design ; Drug Discovery - methods ; Humans ; Models, Biological ; Pharmacology - methods ; Systems Biology - methods</subject><ispartof>Drug discovery today, 2011-12, Vol.16 (23), p.1031-1036</ispartof><rights>2011 Elsevier Ltd</rights><rights>Copyright © 2011 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c361t-69303f38066238bce2a57d5bc92940ce17ade935f8f81f7fcb36deb831b28a753</citedby><cites>FETCH-LOGICAL-c361t-69303f38066238bce2a57d5bc92940ce17ade935f8f81f7fcb36deb831b28a753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22020181$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Agoram, Balaji M.</creatorcontrib><creatorcontrib>Demin, Oleg</creatorcontrib><title>Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development</title><title>Drug discovery today</title><addtitle>Drug Discov Today</addtitle><description>Quantitative and systems pharmacology (QSP) is an emerging modelling technique that combines the flexibility of systems biology and tractability of compartmental pharmacokinetic–pharmacodynamic modelling techniques. Historically, there has been extensive use of QSP within the field of pharmacokinetics to optimise drug biopharmaceutical properties. However, application to target and biomarker selection, and design of preclinical and clinical studies is limited, but growing rapidly. In this article we highlight the impact of QSP within drug discovery and development by citing examples from within the field of pharmacology and we argue for a more systematic integration of QSP within the drug discovery and development paradigm.</description><subject>Animals</subject><subject>Drug Design</subject><subject>Drug Discovery - methods</subject><subject>Humans</subject><subject>Models, Biological</subject><subject>Pharmacology - methods</subject><subject>Systems Biology - methods</subject><issn>1359-6446</issn><issn>1878-5832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp9kEtv3CAUhVGUqnm0_yCq2GXlCQ8b4y4qVVFeUqRs2jXCcO0wsmECeKL592EyaZdZcbn6zr3nHoQuKFlRQsXVemXjYl1aMUJpaa0IoUfolMpWVo3k7LjUvOkqUdfiBJ2ltC4A6xrxFZ0wRopK0lP0-uAzjFFnFzz2IWOXwvT--4l1HBfnR5yfARudAA8h4pdF--xyQbaAtbc47VKGOeHNs46zNmEK4w47j4u7ERd_Jmwh7t5RC1uYwmYGn7-hL4OeEnz_eM_R39ubP9f31ePT3cP178fKcEFzJTpO-MAlEYJx2Rtgumlt05uOdTUxQFttoePNIAdJh3YwPRcWeslpz6RuG36OLg9zNzG8LJCymoslmCbtISxJdaQlXDQ1K2R9IE0MKUUY1Ca6WcedokTtE1drdUhc7RPfd0ugRfbjY8HSz2D_i_5FXIBfBwDKmVsHUSXjwBuwLoLJygb3-YY3VaCWng</recordid><startdate>20111201</startdate><enddate>20111201</enddate><creator>Agoram, Balaji M.</creator><creator>Demin, Oleg</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20111201</creationdate><title>Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development</title><author>Agoram, Balaji M. ; Demin, Oleg</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-69303f38066238bce2a57d5bc92940ce17ade935f8f81f7fcb36deb831b28a753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Drug Design</topic><topic>Drug Discovery - methods</topic><topic>Humans</topic><topic>Models, Biological</topic><topic>Pharmacology - methods</topic><topic>Systems Biology - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Agoram, Balaji M.</creatorcontrib><creatorcontrib>Demin, Oleg</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Drug discovery today</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Agoram, Balaji M.</au><au>Demin, Oleg</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development</atitle><jtitle>Drug discovery today</jtitle><addtitle>Drug Discov Today</addtitle><date>2011-12-01</date><risdate>2011</risdate><volume>16</volume><issue>23</issue><spage>1031</spage><epage>1036</epage><pages>1031-1036</pages><issn>1359-6446</issn><eissn>1878-5832</eissn><abstract>Quantitative and systems pharmacology (QSP) is an emerging modelling technique that combines the flexibility of systems biology and tractability of compartmental pharmacokinetic–pharmacodynamic modelling techniques. Historically, there has been extensive use of QSP within the field of pharmacokinetics to optimise drug biopharmaceutical properties. However, application to target and biomarker selection, and design of preclinical and clinical studies is limited, but growing rapidly. In this article we highlight the impact of QSP within drug discovery and development by citing examples from within the field of pharmacology and we argue for a more systematic integration of QSP within the drug discovery and development paradigm.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>22020181</pmid><doi>10.1016/j.drudis.2011.10.001</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1359-6446
ispartof Drug discovery today, 2011-12, Vol.16 (23), p.1031-1036
issn 1359-6446
1878-5832
language eng
recordid cdi_proquest_miscellaneous_907036542
source Elsevier
subjects Animals
Drug Design
Drug Discovery - methods
Humans
Models, Biological
Pharmacology - methods
Systems Biology - methods
title Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T00%3A29%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Integration%20not%20isolation:%20arguing%20the%20case%20for%20quantitative%20and%20systems%20pharmacology%20in%20drug%20discovery%20and%20development&rft.jtitle=Drug%20discovery%20today&rft.au=Agoram,%20Balaji%20M.&rft.date=2011-12-01&rft.volume=16&rft.issue=23&rft.spage=1031&rft.epage=1036&rft.pages=1031-1036&rft.issn=1359-6446&rft.eissn=1878-5832&rft_id=info:doi/10.1016/j.drudis.2011.10.001&rft_dat=%3Cproquest_cross%3E907036542%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c361t-69303f38066238bce2a57d5bc92940ce17ade935f8f81f7fcb36deb831b28a753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=907036542&rft_id=info:pmid/22020181&rfr_iscdi=true